Emergent BioSolutions (EBS) is up 22.4%, or $1.06 to $5.80.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EBS:
- Emergent BioSolutions Reports Strong Q1 2025 Earnings
- Emergent BioSolutions reports Q1 adjusted EPS 71c, consensus 70c
- Emergent BioSolutions sees Q2 revenue $95M-$120M, consensus $205.67M
- Emergent BioSolutions backs FY25 revenue view $750M-$850M, consensus $819.44M
- Emergent BioSolutions Reports 656% Net Income Surge